Academic Committee
J Christine Ye, MD, MS (Chair)
Dr. Ye is an Associate Professor of Internal Medicine, University of Texas, MD Anderson Cancer Center. She is a board-certified hematologist and oncologist who specializes in treating patients with plasma cell dyscrasia. Dr Ye leads national clinical trials and serves as the vice-chair for National Cancer Institute (NCI) Southwestern Oncology Group (SWOG) Multiple Myeloma Committee.
Zhaouhui Jin, MD (Co-Chair)
Dr. Zhaohui Jin received his MD at Peking Union Medical College in Beijing, China then worked in the Department of hematology at the Sixth People’s Hospital of Shanghai. Dr. Jin came to the United States working as a research fellow at the Shands cancer center, University of Florida in 2002. Dr. Jin moved to Boston and worked as an instructor at Harvard medical school between 2005-2010. Subsequently Dr. Jin completed residency training in New Jersey followed by hematology/oncology fellowship in Iowa. Dr. Jin completed his advanced GI oncology fellowship at Mayo Clinic in 2017. He worked as a clinical assistant professor at University of Illinois Urbana-Champaign (UIUC) for about a year. Dr. Jin then returned to Mayo Clinic in 2/2019 and works as a GI medical oncologist at the Department of Medical oncology.
Tian Zhang, MD, MHS
Dr. Zhang received her MD from the Harvard-MIT Health Sciences and Technology (HST) program at Harvard Medical School and completed clinical training at Duke University. She is currently Associate Professor within the Division of Hematology and Oncology and Department of Internal Medicine at UT Southwestern, specializing in genitourinary (GU) malignancies. She actively leads both clinical and translational research studies in the GU oncology and multi-disease and precision oncology programs in the Harold C Simmons Comprehensive Cancer Center. She is the overall study chair for the phase 3 PDIGREE trial for metastatic renal cell carcinoma in the Alliance cooperative group. Her research focus is in improving novel therapies and biomarkers for patients with GU malignancies.
Wanqing Iris Zhi, MD, PhD
Wanqing Iris Zhi MD PhD is a board-certified medical oncologist and the medical site director at Memorial Sloan Kettering Cancer Center (MSKCC) Commack. Her clinical expertise is in breast cancer as a part of modern multidisciplinary care team. She serves as the principle and co-principal investigator (co-PI) on multiple clinical trials opened by MSK’s Breast Medicine, Radiation Oncology, and Integrative Medicine Services. Dr. Wanqing Iris Zhi received her medical degree from Beijing Medical University, and PhD from Stony Brook University. She completed her hematology and medical oncology training at Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center. Her work has been published extensively on peer-reviewed scientific journals. She is a life member of CAHON since 2015 and has been actively involving CAHON community event services. She is a member of ASCO, AACR, Society of Integrative Oncology (SIO). She also serves research committee of SIO and Older Adult Committee of The Alliance for Clinical Trials in Oncology.